To investigate whether the Akt signal was a key determinant for the antitumor activity of baicalin in lung cancer, we specifically enhanced Akt activation using a pharmacological activator SC79 (5 μM) and the Akt overexpression plasmid. Here, AKT1 is linked to lung cancer.